… rate was observed with erlotinib monotherapy in NSCLC patients… In conclusion, this study
indicates that erlotinib monotherapy … Tumor responses and survival outcomes for erlotinib were …

… [11] Recently, erlotinib monotherapy has been … oral erlotinib as monotherapy for maintenance
treatment in patients with NSCLC. Medical literature on the use of erlotinib as monotherapy …

… safety of Erlotinib in Japanese patients with previously treated non-small cell lung cancer
(… This report presents the results of the first phase II study of erlotinib conducted in Japanese …

… This report represents the first analysis of OS benefit with the combination of erlotinib
plus bevacizumab vs erlotinib monotherapy in EGFR+ NSCLC. The significant PFS benefit …

… agent for this indication was docetaxel as monotherapy (1, 2). No … Pemetrexed and erlotinib
monotherapy have different … On this basis, both agents were approved as monotherapy …

… the combination of bevacizumab and erlotinib was compared with erlotinib monotherapy to
evaluate activity in patients with non-small-cell lung cancer (NSCLC) who were not stratified …

… Erlotinib monotherapy is indicated for the treatment of … Erlotinib monotherapy has shown a
significant improvement … Most commonly reported erlotinib-related adverse effects were rash …

… The analysis showed that hazard ratios of erlotinib therapy … This indicates that erlotinib therapy
might be also beneficial … a phase II trial of erlotinib monotherapy in Japanese patients with …

… Our objective was the preclinical assessment of the pharmacokinetics, monotherapy and …
kinase inhibitor erlotinib in athymic nude mice bearing non-small cell lung cancer (NSCLC) …

… This article presents a summary of the ERG report for the STA of erlotinib as monotherapy
for the maintenance treatment of patients with non-small cell lung cancer (NSCLC) and stable …